Correction: RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells (vol 8, 653, 2018): RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells (Scientific Reports, (2018), 8, 1, (653), 10.1038/s41598-017-18851-4)

Nouar Qutob; Ikuo Masuho; Michal Alon; Rafi Emmanuel; Isadora Cohen; Antonella Di Pizio; Jason Madore; Abdel Elkahloun; Tamar Ziv; Ronen Levy; Jared J. Gartner; Victoria K. Hill; Jimmy C. Lin; Yael Hevroni; Polina Greenberg; Alexandra Brodezki; Steven A. Rosenberg; Mickey Kosloff; Nicholas K. Hayward; Arie Admon; Masha Y. Niv; Richard A. Scolyer; Kirill A. Martemyanov; Yardena Samuels

doi:10.1038/s41598-018-37932-6

Correction: RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells (vol 8, 653, 2018): RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells (Scientific Reports, (2018), 8, 1, (653), 10.1038/s41598-017-18851-4)

Nouar Qutob, Ikuo Masuho, Michal Alon, Rafi Emmanuel, Isadora Cohen, Antonella Di Pizio, Jason Madore, Abdel Elkahloun, Tamar Ziv, Ronen Levy, Jared J. Gartner, Victoria K. Hill, Jimmy C. Lin, Yael Hevroni, Polina Greenberg, Alexandra Brodezki, Steven A. Rosenberg, Mickey Kosloff, Nicholas K. Hayward, Arie AdmonMasha Y. Niv, Richard A. Scolyer, Kirill A. Martemyanov, Yardena Samuels

Weizmann Institute of Science, Technion - Israel Institute of Technology

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The Acknowledgements section in this Article is incomplete.
“We thank Mr. N. K. Skamangas for technical support and Dr. A. Kovoor for the D2 receptor expression plasmid, Dr. H. Itoh for GαoA and Dr. N. Lambert for sharing the Gβγ-Venus constructs. This work was supported by NIH grants DA036596 and DA026405 (KAM). MYN is supported by Israel Science Foundation grant 432/12 and Chief Scientist Ministry of Health (the ERA-NET network) and grant no. 3-9543 from the Chief Scientist Office of the Ministry of Health, Israel via the ERA-net network. MK is supported by Israel Science Foundation grant numbers 1454/13, 1959/13, 2155/15. YS is supported by the Israel Science Foundation grant numbers 1604/13 and 877/13, the ERC (StG-335377), by the Henry Chanoch Krenter Institute for Biomedical Imaging and Genomics, the estate of Alice Schwarz-Gardos, the estate of John Hunter, the Knell Family, the Peter and Patricia Gruber Award and the Hamburger Family. Lady Davis Fellowship to ADP is gratefully acknowledged. NKH and RAS are supported by fellowships from the National Health and Medical Research Council of Australia.”

Original language	English
Article number	4523
Number of pages	2
Journal	Scientific Reports
Volume	9
Issue number	1
DOIs	https://doi.org/10.1038/s41598-018-37932-6
State	Published - 9 Mar 2019

All Science Journal Classification (ASJC) codes

General

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41598-018-37932-6License: CC BY

Fingerprint

Dive into the research topics of 'Correction: RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells (vol 8, 653, 2018): RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells (Scientific Reports, (2018), 8, 1, (653), 10.1038/s41598-017-18851-4)'. Together they form a unique fingerprint.

Cite this

Qutob, N., Masuho, I., Alon, M., Emmanuel, R., Cohen, I., Di Pizio, A., Madore, J., Elkahloun, A., Ziv, T., Levy, R., Gartner, J. J., Hill, V. K., Lin, J. C., Hevroni, Y., Greenberg, P., Brodezki, A., Rosenberg, S. A., Kosloff, M., Hayward, N. K., ... Samuels, Y. (2019). Correction: RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells (vol 8, 653, 2018): RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells (Scientific Reports, (2018), 8, 1, (653), 10.1038/s41598-017-18851-4). Scientific Reports, 9(1), Article 4523. https://doi.org/10.1038/s41598-018-37932-6

Qutob, Nouar ; Masuho, Ikuo ; Alon, Michal et al. / Correction: RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells (vol 8, 653, 2018) : RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells (Scientific Reports, (2018), 8, 1, (653), 10.1038/s41598-017-18851-4). In: Scientific Reports. 2019 ; Vol. 9, No. 1.

@article{97b2c074ae4c4b7a8619b766dbe75efe,

title = "Correction: RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells (vol 8, 653, 2018): RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells (Scientific Reports, (2018), 8, 1, (653), 10.1038/s41598-017-18851-4)",

abstract = "The Acknowledgements section in this Article is incomplete.“We thank Mr. N. K. Skamangas for technical support and Dr. A. Kovoor for the D2 receptor expression plasmid, Dr. H. Itoh for GαoA and Dr. N. Lambert for sharing the Gβγ-Venus constructs. This work was supported by NIH grants DA036596 and DA026405 (KAM). MYN is supported by Israel Science Foundation grant 432/12 and Chief Scientist Ministry of Health (the ERA-NET network) and grant no. 3-9543 from the Chief Scientist Office of the Ministry of Health, Israel via the ERA-net network. MK is supported by Israel Science Foundation grant numbers 1454/13, 1959/13, 2155/15. YS is supported by the Israel Science Foundation grant numbers 1604/13 and 877/13, the ERC (StG-335377), by the Henry Chanoch Krenter Institute for Biomedical Imaging and Genomics, the estate of Alice Schwarz-Gardos, the estate of John Hunter, the Knell Family, the Peter and Patricia Gruber Award and the Hamburger Family. Lady Davis Fellowship to ADP is gratefully acknowledged. NKH and RAS are supported by fellowships from the National Health and Medical Research Council of Australia.”",

author = "Nouar Qutob and Ikuo Masuho and Michal Alon and Rafi Emmanuel and Isadora Cohen and \{Di Pizio\}, Antonella and Jason Madore and Abdel Elkahloun and Tamar Ziv and Ronen Levy and Gartner, \{Jared J.\} and Hill, \{Victoria K.\} and Lin, \{Jimmy C.\} and Yael Hevroni and Polina Greenberg and Alexandra Brodezki and Rosenberg, \{Steven A.\} and Mickey Kosloff and Hayward, \{Nicholas K.\} and Arie Admon and Niv, \{Masha Y.\} and Scolyer, \{Richard A.\} and Martemyanov, \{Kirill A.\} and Yardena Samuels",

note = "NA",

year = "2019",

month = mar,

day = "9",

doi = "10.1038/s41598-018-37932-6",

language = "الإنجليزيّة",

volume = "9",

journal = "Scientific Reports",

issn = "2045-2322",

publisher = "Nature Publishing Group",

number = "1",

}

Qutob, N, Masuho, I, Alon, M, Emmanuel, R, Cohen, I, Di Pizio, A, Madore, J, Elkahloun, A, Ziv, T, Levy, R, Gartner, JJ, Hill, VK, Lin, JC, Hevroni, Y, Greenberg, P, Brodezki, A, Rosenberg, SA, Kosloff, M, Hayward, NK, Admon, A, Niv, MY, Scolyer, RA, Martemyanov, KA & Samuels, Y 2019, 'Correction: RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells (vol 8, 653, 2018): RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells (Scientific Reports, (2018), 8, 1, (653), 10.1038/s41598-017-18851-4)', Scientific Reports, vol. 9, no. 1, 4523. https://doi.org/10.1038/s41598-018-37932-6

Correction: RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells (vol 8, 653, 2018): RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells (Scientific Reports, (2018), 8, 1, (653), 10.1038/s41598-017-18851-4). / Qutob, Nouar; Masuho, Ikuo; Alon, Michal et al.
In: Scientific Reports, Vol. 9, No. 1, 4523, 09.03.2019.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Correction: RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells (vol 8, 653, 2018)

T2 - RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells (Scientific Reports, (2018), 8, 1, (653), 10.1038/s41598-017-18851-4)

AU - Qutob, Nouar

AU - Masuho, Ikuo

AU - Alon, Michal

AU - Emmanuel, Rafi

AU - Cohen, Isadora

AU - Di Pizio, Antonella

AU - Madore, Jason

AU - Elkahloun, Abdel

AU - Ziv, Tamar

AU - Levy, Ronen

AU - Gartner, Jared J.

AU - Hill, Victoria K.

AU - Lin, Jimmy C.

AU - Hevroni, Yael

AU - Greenberg, Polina

AU - Brodezki, Alexandra

AU - Rosenberg, Steven A.

AU - Kosloff, Mickey

AU - Hayward, Nicholas K.

AU - Admon, Arie

AU - Niv, Masha Y.

AU - Scolyer, Richard A.

AU - Martemyanov, Kirill A.

AU - Samuels, Yardena

N1 - NA

PY - 2019/3/9

Y1 - 2019/3/9

N2 - The Acknowledgements section in this Article is incomplete.“We thank Mr. N. K. Skamangas for technical support and Dr. A. Kovoor for the D2 receptor expression plasmid, Dr. H. Itoh for GαoA and Dr. N. Lambert for sharing the Gβγ-Venus constructs. This work was supported by NIH grants DA036596 and DA026405 (KAM). MYN is supported by Israel Science Foundation grant 432/12 and Chief Scientist Ministry of Health (the ERA-NET network) and grant no. 3-9543 from the Chief Scientist Office of the Ministry of Health, Israel via the ERA-net network. MK is supported by Israel Science Foundation grant numbers 1454/13, 1959/13, 2155/15. YS is supported by the Israel Science Foundation grant numbers 1604/13 and 877/13, the ERC (StG-335377), by the Henry Chanoch Krenter Institute for Biomedical Imaging and Genomics, the estate of Alice Schwarz-Gardos, the estate of John Hunter, the Knell Family, the Peter and Patricia Gruber Award and the Hamburger Family. Lady Davis Fellowship to ADP is gratefully acknowledged. NKH and RAS are supported by fellowships from the National Health and Medical Research Council of Australia.”

AB - The Acknowledgements section in this Article is incomplete.“We thank Mr. N. K. Skamangas for technical support and Dr. A. Kovoor for the D2 receptor expression plasmid, Dr. H. Itoh for GαoA and Dr. N. Lambert for sharing the Gβγ-Venus constructs. This work was supported by NIH grants DA036596 and DA026405 (KAM). MYN is supported by Israel Science Foundation grant 432/12 and Chief Scientist Ministry of Health (the ERA-NET network) and grant no. 3-9543 from the Chief Scientist Office of the Ministry of Health, Israel via the ERA-net network. MK is supported by Israel Science Foundation grant numbers 1454/13, 1959/13, 2155/15. YS is supported by the Israel Science Foundation grant numbers 1604/13 and 877/13, the ERC (StG-335377), by the Henry Chanoch Krenter Institute for Biomedical Imaging and Genomics, the estate of Alice Schwarz-Gardos, the estate of John Hunter, the Knell Family, the Peter and Patricia Gruber Award and the Hamburger Family. Lady Davis Fellowship to ADP is gratefully acknowledged. NKH and RAS are supported by fellowships from the National Health and Medical Research Council of Australia.”

UR - http://www.scopus.com/inward/record.url?scp=85062622165&partnerID=8YFLogxK

U2 - 10.1038/s41598-018-37932-6

DO - 10.1038/s41598-018-37932-6

M3 - تعليقَ / نقاش

SN - 2045-2322

VL - 9

JO - Scientific Reports

JF - Scientific Reports

IS - 1

M1 - 4523

ER -

Qutob N, Masuho I, Alon M, Emmanuel R, Cohen I, Di Pizio A et al. Correction: RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells (vol 8, 653, 2018): RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells (Scientific Reports, (2018), 8, 1, (653), 10.1038/s41598-017-18851-4). Scientific Reports. 2019 Mar 9;9(1):4523. doi: 10.1038/s41598-018-37932-6

Correction: RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells (vol 8, 653, 2018): RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells (Scientific Reports, (2018), 8, 1, (653), 10.1038/s41598-017-18851-4)

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this